← Open Payments lookup

MARK OGLE: Open Payments

NPI 1801842422 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$642 in 36 payments from 12 companies in 2025. Trend: 2023 $728 · 2024 $492 · 2025 $642

Food & beverage: $642
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.10$169
ABBVIE INC.5$102
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$76
Neurocrine BioSciences, Inc.3$59
Otsuka America Pharmaceutical, Inc.3$53
Axsome Therapeutics, Inc.3$51
Lundbeck LLC2$33
Teva Pharmaceuticals USA, Inc.2$30
E.R. Squibb & Sons, L.L.C.1$19
Almatica Pharma LLC1$19

Products named: HETLIOZ, VRAYLAR, REXULTI, CAPLYTA, INGREZZA, Auvelity, AUSTEDO XR, COBENFY.

Industry payments across IN — which companies pay providers there.